₩48,900+6.07%
2026-10-06 closeHanall Biopharma's published financial data is dated 2026-10-04. 2024 revenue was KRW 138.94B. 2024 operating profit was KRW 284M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Hanall Biopharma's published financial data is dated 2026-10-04. 2024 revenue was KRW 138.94B. 2024 operating profit was KRW 284M.